Agentix Corp. (AGTX): Net Income
-$485.6K
Year ended 2026-03-31
-$417.5K
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | -$485.6K | n/m | 2026-07-01, From 2025-04-01 |
| 2025-03-31 | -$567.0K | n/m | 2026-07-01, From 2024-04-01 |
| 2024-03-31 | -$585.2K | n/m | 2025-07-16, From 2023-04-01 |
| 2023-03-31 | -$1.37M | n/m | 2024-08-30, From 2022-04-01 |
| 2022-03-31 | -$2.63M | n/a | 2023-07-14, From 2021-04-01 |
| No annual figure between 2019-08-31 and 2022-03-31. | |||
| 2019-08-31 | -$132.7K | n/m | 2019-12-05, From 2018-09-01 |
| 2018-08-31 | -$42.79M | n/m | 2019-12-05, From 2017-09-01 |
| 2017-08-31 | -$381.1K | n/m | 2018-11-13, From 2016-09-01 |
| 2016-08-31 | -$295.6K | n/m | 2017-12-18, From 2015-09-01 |
| 2015-08-31 | -$175.1K | n/m | 2016-12-12, From 2014-09-01 |
| 2014-08-31 | -$208.9K | n/a | 2015-12-16, From 2013-09-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Agentix Corp. (AGTX) | 2026-03-31 | -$485.6K | n/m |
| Mosaic ImmunoEngineering Inc. (CPMV) | 2025-12-31 | -$687.8K | n/m |
| Liminatus Pharma, Inc. (LIMN) | 2025-12-31 | -$10.21M | n/m |
| Adaptin Bio, Inc. (APTN) | 2025-12-31 | -$5.17M | n/m |
| Brainstorm Cell Therapeutics Inc. (BCLI) | 2025-12-31 | -$10.31M | n/m |
| Abpro Holdings, Inc. (ABPO) | 2025-12-31 | -$2.89M | n/m |
| Zeo ScientifiX, Inc. (ZEOX) | 2025-10-31 | -$5.52M | n/m |
| Zivo Bioscience, Inc. (ZIVO) | 2024-12-31 | -$13.38M | n/m |
| Estrella Immunopharma, Inc. (ESLA) | 2025-12-31 | -$13.06M | n/a |
Compare AGTX, CPMV, LIMN, APTN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗